IBDEI21S ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34327,2)
 ;;=^5003773
 ;;^UTILITY(U,$J,358.3,34328,0)
 ;;=G23.8^^157^1744^3
 ;;^UTILITY(U,$J,358.3,34328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34328,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia
 ;;^UTILITY(U,$J,358.3,34328,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,34328,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,34329,0)
 ;;=G47.61^^157^1744^14
 ;;^UTILITY(U,$J,358.3,34329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34329,1,3,0)
 ;;=3^Periodic Limb Movement Disorder
 ;;^UTILITY(U,$J,358.3,34329,1,4,0)
 ;;=4^G47.61
 ;;^UTILITY(U,$J,358.3,34329,2)
 ;;=^5003987
 ;;^UTILITY(U,$J,358.3,34330,0)
 ;;=G23.1^^157^1744^15
 ;;^UTILITY(U,$J,358.3,34330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34330,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,34330,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,34330,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,34331,0)
 ;;=G47.52^^157^1744^16
 ;;^UTILITY(U,$J,358.3,34331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34331,1,3,0)
 ;;=3^REM Sleep Behavior Disorder
 ;;^UTILITY(U,$J,358.3,34331,1,4,0)
 ;;=4^G47.52
 ;;^UTILITY(U,$J,358.3,34331,2)
 ;;=^332778
 ;;^UTILITY(U,$J,358.3,34332,0)
 ;;=G23.2^^157^1744^19
 ;;^UTILITY(U,$J,358.3,34332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34332,1,3,0)
 ;;=3^Striatonigral Degeneration
 ;;^UTILITY(U,$J,358.3,34332,1,4,0)
 ;;=4^G23.2
 ;;^UTILITY(U,$J,358.3,34332,2)
 ;;=^5003781
 ;;^UTILITY(U,$J,358.3,34333,0)
 ;;=F95.2^^157^1744^21
 ;;^UTILITY(U,$J,358.3,34333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34333,1,3,0)
 ;;=3^Tourett's Disorder
 ;;^UTILITY(U,$J,358.3,34333,1,4,0)
 ;;=4^F95.2
 ;;^UTILITY(U,$J,358.3,34333,2)
 ;;=^331942
 ;;^UTILITY(U,$J,358.3,34334,0)
 ;;=G21.4^^157^1744^23
 ;;^UTILITY(U,$J,358.3,34334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34334,1,3,0)
 ;;=3^Vascular Parkinsonism
 ;;^UTILITY(U,$J,358.3,34334,1,4,0)
 ;;=4^G21.4
 ;;^UTILITY(U,$J,358.3,34334,2)
 ;;=^5003776
 ;;^UTILITY(U,$J,358.3,34335,0)
 ;;=I69.393^^157^1744^1
 ;;^UTILITY(U,$J,358.3,34335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34335,1,3,0)
 ;;=3^Ataxia following Cerebral Infarction
 ;;^UTILITY(U,$J,358.3,34335,1,4,0)
 ;;=4^I69.393
 ;;^UTILITY(U,$J,358.3,34335,2)
 ;;=^5007518
 ;;^UTILITY(U,$J,358.3,34336,0)
 ;;=C71.9^^157^1745^5
 ;;^UTILITY(U,$J,358.3,34336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34336,1,3,0)
 ;;=3^Malig Neop Brain,Unspec
 ;;^UTILITY(U,$J,358.3,34336,1,4,0)
 ;;=4^C71.9
 ;;^UTILITY(U,$J,358.3,34336,2)
 ;;=^5001297
 ;;^UTILITY(U,$J,358.3,34337,0)
 ;;=C72.0^^157^1745^7
 ;;^UTILITY(U,$J,358.3,34337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34337,1,3,0)
 ;;=3^Malig Neop Spinal Cord
 ;;^UTILITY(U,$J,358.3,34337,1,4,0)
 ;;=4^C72.0
 ;;^UTILITY(U,$J,358.3,34337,2)
 ;;=^267292
 ;;^UTILITY(U,$J,358.3,34338,0)
 ;;=C72.1^^157^1745^6
 ;;^UTILITY(U,$J,358.3,34338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34338,1,3,0)
 ;;=3^Malig Neop Cauda Equina
 ;;^UTILITY(U,$J,358.3,34338,1,4,0)
 ;;=4^C72.1
 ;;^UTILITY(U,$J,358.3,34338,2)
 ;;=^5001298
 ;;^UTILITY(U,$J,358.3,34339,0)
 ;;=C79.31^^157^1745^8
 ;;^UTILITY(U,$J,358.3,34339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34339,1,3,0)
 ;;=3^Secondary Malig Neop Brain
 ;;^UTILITY(U,$J,358.3,34339,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,34339,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,34340,0)
 ;;=D32.0^^157^1745^1
 ;;^UTILITY(U,$J,358.3,34340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34340,1,3,0)
 ;;=3^Benign Neop Cerebral Meninges
 ;;^UTILITY(U,$J,358.3,34340,1,4,0)
 ;;=4^D32.0
 ;;^UTILITY(U,$J,358.3,34340,2)
 ;;=^267681
 ;;^UTILITY(U,$J,358.3,34341,0)
 ;;=D33.4^^157^1745^3
